Form 8-K - Current report:
SEC Accession No. 0000950170-21-004083
Filing Date
2021-11-10
Accepted
2021-11-10 16:12:57
Documents
13
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20211110.htm   iXBRL 8-K 54889
2 EX-99.1 acet-ex99_1.htm EX-99.1 161091
  Complete submission text file 0000950170-21-004083.txt   355175

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20211110.xsd EX-101.SCH 2495
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20211110_lab.xml EX-101.LAB 19138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20211110_pre.xml EX-101.PRE 11504
6 EXTRACTED XBRL INSTANCE DOCUMENT acet-20211110_htm.xml XML 4876
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 211396726
SIC: 2834 Pharmaceutical Preparations